Topic: Chemical Imbalance

Dr. Roger McFillan traces the history of modern psychiatry back to the 1987 FDA approval of Prozac, noting a dramatic shift in how society views suffering. Before the 1990s, difficult emotions were viewed as normal signals for life changes, but direct-to-consumer advertising transformed these experiences into medical diseases. The discussion highlights the "chemical imbalance" narrative as a marketing tool used to create lifelong drug dependency without objective biological measurements.

A 2022 systemic umbrella study by Dr. Joanna Moncrief is cited as definitive proof that serotonin levels are not correlated with depression. The discussion emphasizes that SSRIs do not correct an imbalance but instead induce a chemical abnormality that can lead to chronic depression and metabolic illness. Despite this scientific debunking, surveys suggest that over 80% of the American public still believes the debunked chemical imbalance myth.